ECSP23025022A - Composiciones probióticas para el tratamiento del acné - Google Patents

Composiciones probióticas para el tratamiento del acné

Info

Publication number
ECSP23025022A
ECSP23025022A ECSENADI202325022A ECDI202325022A ECSP23025022A EC SP23025022 A ECSP23025022 A EC SP23025022A EC SENADI202325022 A ECSENADI202325022 A EC SENADI202325022A EC DI202325022 A ECDI202325022 A EC DI202325022A EC SP23025022 A ECSP23025022 A EC SP23025022A
Authority
EC
Ecuador
Prior art keywords
acne
treatment
probiotic compositions
bacterial strain
compositions
Prior art date
Application number
ECSENADI202325022A
Other languages
English (en)
Inventor
Moratalla Laura Navarro
López Vicente Navarro
Original Assignee
Bionou Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Res S L filed Critical Bionou Res S L
Publication of ECSP23025022A publication Critical patent/ECSP23025022A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan composiciones probióticas en la presente invención que comprenden las cepas bacterianas L. rhamnosus CECT 30031 y la cepa bacteriana Arthrospira platensis (Spirulina paraca). Las composiciones probióticas divulgadas son útiles en el tratamiento del acné.
ECSENADI202325022A 2020-09-14 2023-04-06 Composiciones probióticas para el tratamiento del acné ECSP23025022A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20382805.8A EP3967318A1 (en) 2020-09-14 2020-09-14 Probiotic compositions for the treatment of acne

Publications (1)

Publication Number Publication Date
ECSP23025022A true ECSP23025022A (es) 2023-06-30

Family

ID=72744714

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202325022A ECSP23025022A (es) 2020-09-14 2023-04-06 Composiciones probióticas para el tratamiento del acné

Country Status (14)

Country Link
US (1) US20240033308A1 (es)
EP (2) EP3967318A1 (es)
JP (1) JP2023541269A (es)
CN (1) CN117042785A (es)
AU (1) AU2021340244A1 (es)
CA (1) CA3195208A1 (es)
CL (1) CL2023000720A1 (es)
CO (1) CO2023004516A2 (es)
CR (1) CR20230144A (es)
DO (1) DOP2023000047A (es)
EC (1) ECSP23025022A (es)
MX (1) MX2023002993A (es)
PE (1) PE20231500A1 (es)
WO (1) WO2022053711A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2503340T3 (es) * 2004-11-03 2014-10-06 Biovite Australia Pty Ltd Composiciones a base de Arthrospira y usos de los mismos
AU2008201391A1 (en) * 2007-03-30 2008-10-16 Gc Corporation A method for measuring the number of oral lactobacillus, and a PCR primers-probe set used for the same
DE102011107307A1 (de) * 2011-07-06 2013-01-10 Ocean Research & Development Gmbh Verfahren zur Herstellung eines pharmazeutisch wirksamen Extrakts aus Arthrospira spec.
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US10767156B2 (en) * 2013-10-24 2020-09-08 Yeda Research And Development Co., Ltd. Polynucleotides encoding BREX system polypeptides and methods of using same
KR101612509B1 (ko) * 2014-06-11 2016-04-15 한국식품연구원 피부상태 개선 효과를 가지는 스피루리나 변이균주
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
CN109315769A (zh) * 2018-09-04 2019-02-12 丽睿客信息科技（北京）有限公司 一种用于改善人体肠内环境的组合物及其制备方法

Also Published As

Publication number Publication date
CA3195208A1 (en) 2022-03-17
CN117042785A (zh) 2023-11-10
EP4210720B1 (en) 2024-08-21
EP3967318A1 (en) 2022-03-16
JP2023541269A (ja) 2023-09-29
DOP2023000047A (es) 2023-06-30
MX2023002993A (es) 2023-05-18
AU2021340244A1 (en) 2023-05-11
US20240033308A1 (en) 2024-02-01
EP4210720A1 (en) 2023-07-19
WO2022053711A1 (en) 2022-03-17
CO2023004516A2 (es) 2023-06-20
CL2023000720A1 (es) 2023-10-30
CR20230144A (es) 2023-07-06
PE20231500A1 (es) 2023-09-26

Similar Documents

Publication Publication Date Title
CO2018005217A2 (es) Composición que comprende una cepa bacteriana del género enterococcus gallinarum
CO2018005226A2 (es) Composición que comprende una cepa bacteriana del género erysipelatoclostridium
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
AR107921A1 (es) Uso de probióticos en el tratamiento y/o la prevención de la enfermedad de la psoriasis
CO2018005207A2 (es) Composición que comprende una cepa bacteriana de la especie enterococcus faecium
AR112328A1 (es) Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
CL2019002641A1 (es) Composiciones y métodos que involucran moléculas probióticas.
PE20190417A1 (es) Uso de probioticos en el tratamiento y/o la prevencion de la dermatitis atopica
CO6270334A2 (es) Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis
CL2018001936A1 (es) Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.
CO2017007338A2 (es) Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina
CO2022015278A2 (es) Células genéticamente modificadas enriquecidas con mitocondrias y usos de estas
BR112022024128A2 (pt) Composição de microbiota vaginal, e, método para tratar uma infecção
CL2019003595A1 (es) Bacterias probióticas preacondicionadas en un medio que contiene gos y uso de estas.
ECSP23025022A (es) Composiciones probióticas para el tratamiento del acné
CO2022003742A2 (es) Conjugados de interleuquina 10 y sus usos
BR112022017567A2 (pt) Composições para cuidados pessoais
ECSP22004680A (es) Anticuerpos anti-angpt2
AR101538A1 (es) Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden
EA201992649A1 (ru) Композиции, содержащие бактериальные штаммы
CL2022003531A1 (es) Probióticos de origen porcino que promueven la salud y el rendimiento del crecimiento en cerdos.
AR080106A1 (es) Composiciones y metodos para restringir la colonizacion de uno o mas patogenos en el intestino de un vertebrado por medio de exclusion competitiva
AR112899A1 (es) Vesículas extracelulares de prevotella en composición farmacéutica
Tehrani et al. The effect of some lactobacillus species (probiotics) on biofilm inhibition in Enterococcus faecium